We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Smart Nanoparticles Designed to Identify, Target, and Kill Cancer Cells

By LabMedica International staff writers
Posted on 07 Apr 2010
Nanoparticles have been designed that can identify, target, and destroy specific cancer cells while leaving healthy cells alone.

Led by Dr. More...
Carl Batt, a professor of food science at Cornell University (Ithaca, NY, USA), the researchers synthesized nanoparticles--shaped similar to a dumbbell --made of gold sandwiched between two pieces of iron oxide. They then attached antibodies, which target a molecule found only in colorectal cancer cells, to the particles. Once bound, the nanoparticles are engulfed by the cancer cells.

To kill the cells, the researchers used a near-infrared laser, which is a wavelength that does not harm normal tissue at the levels utilized, but the radiation is absorbed by the gold in the nanoparticles. This causes the cancer cells to heat up and die. "This is a so-called ‘smart' therapy,” Dr. Batt said. "To be a smart therapy, it should be targeted, and it should have some ability to be activated only when it's there and then kills just the cancer cells.”

The goal, according to lead author and biomedical graduate student Dickson Kirui, is to improve the technology and make it suitable for testing in a human clinical trial. The researchers are now working on a similar experiment targeting prostate cancer cells. "If, down the line, you could clinically just target the cancer cells, you could then spare the health surrounding cells from being harmed--that is the critical thing,” Mr. Kirui said.

Gold has potential as a material key to combating cancer in future smart therapies. It is biocompatible, inert, and comparatively easy to modify chemically. By changing the size and shape of the gold particle, the investigators can tune them to respond to different wavelengths of energy.

Once taken up by the researchers' gold particles, the cancer cells are destroyed by heat--just a few degrees above normal body temperature--while the surrounding tissue is left unharmed. Such a low-power laser does not have any effect on surrounding cells because that specific wavelength does not heat up cells if they are not loaded up with nanoparticles, the researchers explained.

Using iron oxide, which is essentially rust, as the other parts of the particles might one day allow scientists to also track the progress of cancer treatments using magnetic resonance imaging, Mr. Kirui noted, by taking advantage of the particles' magnetic properties.

The research was published in the February 15, 2010, online edition of the journal Nanotechnology.

Related Links:

Cornell University




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.